The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA - PubMed (original) (raw)
The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA
L H Hansen et al. Mol Microbiol. 1999 Jan.
Free article
Abstract
The macrolide antibiotic erythromycin interacts with bacterial 23S ribosomal RNA (rRNA) making contacts that are limited to hairpin 35 in domain II of the rRNA and to the peptidyl transferase loop in domain V. These two regions are probably folded close together in the 23S rRNA tertiary structure and form a binding pocket for macrolides and other drug types. Erythromycin has been derivatized by replacing the L-cladinose moiety at position 3 by a keto group (forming the ketolide antibiotics) and by an alkyl-aryl extension at positions 11/12 of the lactone ring. All the drugs footprint identically within the peptidyl transferase loop, giving protection against chemical modification at A2058, A2059 and G2505, and enhancing the accessibility of A2062. However, the ketolide derivatives bind to ribosomes with widely varying affinities compared with erythromycin. This variation correlates with differences in the hairpin 35 footprints. Erythromycin enhances the modification at position A752. Removal of cladinose lowers drug binding 70-fold, with concomitant loss of the A752 footprint. However, the 11/12 extension strengthens binding 10-fold, and position A752 becomes protected. These findings indicate how drug derivatization can improve the inhibition of bacteria that have macrolide resistance conferred by changes in the peptidyl transferase loop.
Similar articles
- A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
Xiong L, Shah S, Mauvais P, Mankin AS. Xiong L, et al. Mol Microbiol. 1999 Jan;31(2):633-9. doi: 10.1046/j.1365-2958.1999.01203.x. Mol Microbiol. 1999. PMID: 10027979 - Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
Poulsen SM, Kofoed C, Vester B. Poulsen SM, et al. J Mol Biol. 2000 Dec 1;304(3):471-81. doi: 10.1006/jmbi.2000.4229. J Mol Biol. 2000. PMID: 11090288 - Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Douthwaite S, Hansen LH, Mauvais P. Douthwaite S, et al. Mol Microbiol. 2000 Apr;36(1):183-93. doi: 10.1046/j.1365-2958.2000.01841.x. Mol Microbiol. 2000. PMID: 10760175 - Recognition determinants for proteins and antibiotics within 23S rRNA.
Douthwalte S, Voldborg B, Hansen LH, Rosendahl G, Vester B. Douthwalte S, et al. Biochem Cell Biol. 1995 Nov-Dec;73(11-12):1179-85. doi: 10.1139/o95-127. Biochem Cell Biol. 1995. PMID: 8722035 Review. - Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
Douthwaite S, Champney WS. Douthwaite S, et al. J Antimicrob Chemother. 2001 Sep;48 Suppl T1:1-8. doi: 10.1093/jac/48.suppl_2.1. J Antimicrob Chemother. 2001. PMID: 11566971 Review.
Cited by
- RNA-Ligand Interactions Quantified by Surface Plasmon Resonance with Reference Subtraction.
Arney JW, Weeks KM. Arney JW, et al. Biochemistry. 2022 Aug 2;61(15):1625-1632. doi: 10.1021/acs.biochem.2c00177. Epub 2022 Jul 8. Biochemistry. 2022. PMID: 35802500 Free PMC article. - Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
Svetlov MS, Koller TO, Meydan S, Shankar V, Klepacki D, Polacek N, Guydosh NR, Vázquez-Laslop N, Wilson DN, Mankin AS. Svetlov MS, et al. Nat Commun. 2021 May 14;12(1):2803. doi: 10.1038/s41467-021-23068-1. Nat Commun. 2021. PMID: 33990576 Free PMC article. - Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance.
Svetlov MS, Syroegin EA, Aleksandrova EV, Atkinson GC, Gregory ST, Mankin AS, Polikanov YS. Svetlov MS, et al. Nat Chem Biol. 2021 Apr;17(4):412-420. doi: 10.1038/s41589-020-00715-0. Epub 2021 Jan 18. Nat Chem Biol. 2021. PMID: 33462493 Free PMC article. - Investigation of Macrolide Resistance Genotypes in Mycoplasma bovis Isolates from Canadian Feedlot Cattle.
Kinnear A, McAllister TA, Zaheer R, Waldner M, Ruzzini AC, Andrés-Lasheras S, Parker S, Hill JE, Jelinski MD. Kinnear A, et al. Pathogens. 2020 Jul 30;9(8):622. doi: 10.3390/pathogens9080622. Pathogens. 2020. PMID: 32751555 Free PMC article. - Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the E. coli 70S ribosome.
Pichkur EB, Paleskava A, Tereshchenkov AG, Kasatsky P, Komarova ES, Shiriaev DI, Bogdanov AA, Dontsova OA, Osterman IA, Sergiev PV, Polikanov YS, Myasnikov AG, Konevega AL. Pichkur EB, et al. RNA. 2020 Jun;26(6):715-723. doi: 10.1261/rna.073817.119. Epub 2020 Mar 6. RNA. 2020. PMID: 32144191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases